
Lumpy Government, Unproven Sequels—25% Growth On Track If Execution Holds
Government diagnostics · TB program · Rate contract delay
BSE: 544866
P/L Snapshot
Q1 FY27 · standalone
Shareholding
Pattern breakdown
P/L Trends
(in crores)

Government diagnostics · TB program · Rate contract delay

Government tenders · Truenant platform · Veterinary expansion

point-of-care · Truenat · OptraScan
Corporate Events
Board Meeting
To consider and approve the Unaudited financial results (Sta…
BSE Filing ↗Board Meeting
The Board of Directors considered and approved the re-appoin…
BSE Filing ↗Board Meeting
Approval of Un-audited Financial Results (Standalone & Conso…
BSE Filing ↗Board Meeting
The Board of Directors of the Company at their meeting held …
BSE Filing ↗